APPLICATION
ANDA209582
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-28
LATEST ACTION
2026-01-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 100MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 50MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 150MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 75MG BASE · TABLET · ORAL
Approval history
2026-01-17Labeling · Supplement 1 · standardAP
2026-01-17Labeling · Supplement 8 · standardAP
2026-01-17Labeling · Supplement 6 · standardAP
2017-09-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.